Investment Q&A

Q: how would you rank the most promising junior lithium companies based on management, capitalization, promising land in development, and/or near or in production .. much thx

Q: BAM.a is one of u top favourites. As per u advices,bought @ $44.49 & add recently @ $71.46.It has dropped from some $78 H near end of Dec.tocurrent levels where it seems to stabilize.Is it advisable to some at this level in view of the current backdrop. Txs for U usual great services & views

Q: Hi 5I
I have my rent coverage in TCN. IIP.un, O, and IIPR. The portfolio weighting is fine, I believe(3% total). I am happy with the growth and payout of TCN & IIP
Question: I noticed your preference is to ZRE for income. Should I consider switching into ZRE going forward(TCN for ZRE)? Any other comments are appreciated.

Q: I might have missed it but in reviewing your portfolios I notice these two names absent. I hold them for longer term gains but am wondering now if they may be more risky in an adverse even "bear" market?
Thank you

Q: How would you characterize this bank (tech/private equity proxy?) and with its recent fall would you see it as more reasonably valued and an opportunity now? Thanks

Q: are the dividends fairly safe on these two, and which one would be the better investment? thanks

Q: which of these two would you own first and why ? thanks

Q: both of these gold producers have high target prices , would they both be good or not ?

Q: Hi 5i,
Two questions if that's OK, and please deduct accordingly.
In October you counseled me to not sell ATZ when it had reached $50 and I was tempted. I'm glad I listened to your advice then and held on as it's now up a another $8 and my gain is about 90%. Your advice then might still hold - don't sell the stock just because it's up. But the economic backdrop is considerably different now than it was in October and I wonder if you would still counsel holding on, especially since a lot of what otherwise might be discretionary income could be going to servicing debt going forward, and consumers might just generally feel like reining in the spending.
Also - CURA has not been so kind to me and I'm down 50%, meaning I need a 100% gain from here to get back to square one. My understanding is that it is a good company but the regulatory framework in the US hasn't changed as was needed/expected, and the stock is therefore wallowing. So, sell and put the money to work elsewhere, or ride it out for a while, bearing in mind it needs to do very well to even begin to heal the wound it caused?
Both are in a TFSA.
Thanks!
Peter

Q: Hello 5i
I recently asked a question regarding US stocks and etf positions. You suggested that I could easily go with the stocks I have plus something like VTI. I currently hold RSP ( as I like an equal weight approach and it maybe more readily balances my overweight in technology) and IWO for small caps. Do you think that this would serve as well as VTI?

Q: Hello 5i
I am a value investor with some growth positions LSPD, LNS). Having learned from LSPD I trimmed some Leon's. The yield of ZIM seems excessive but the company has been improving over the years, dept is improving and it is showing a profit. Is the yield sustainable? Does it fir a profile as a value investor with 10 year outlook in need of industrials and global invesment?
Thank you
Stanley

Q: Regarding Jerome Powell, is quoted today as saying he "Pointed to an economy in 'a different situation' from the last interest-rate hiking cycle, highlighting a tighter labour market, the fastest inflation since the 1980's,"
The 1980's were great for interest -- I locked in a GIC for 5 years at 17% annual compound growth.
For the outlook today, can you provide any advice on what to do an what not to do give the outlook above,
Thanks for your valued advice.

Q: I own small positions in Fiera, Firm Capital, Alaris and Mcan for their outsized yields. I'm close to even on three and down 5% on Fiera (8 5% yield).
Would you keep them as long term investments and please rank them. Thanks.

Q: Would you recommend to buy some short term put options to help protect a portfolio from anymore downside risk. If so would you do this in names you already own or look for some tech names that might be still overvalued.

Q: In a Jan 28th response you stated cash had declined and there is maybe a need to raise capital. This is a company that has grown by acquisition, which usually requires cash. Has the outlook changed drastically in a short period and now they have cash flow issues? Is the status of their cash flow available before the quarterly report?
A potential sale of the company was also mentioned. Can you reference any additional information regarding the sale of the company? Thanks.

Q: Good day.

1. I am considering the purchase of mentioned. I did some quick research and noticed that on Jan 19th you mentioned in a response that it had a P/E of 15. Looking at its profile on your site and the BMO site, it shows 9.x.

If I look at the current stock price of $142 and its EPS of $15.66 (from its profile), this would correspond with the P/E of 9.x (which would not even be its forward looking P/E but its historical).

Am I missing something here? It appears to be a great deal.

2. I read your Jan 18,2022 report about this company. At the very top of the report (on the right hand side) it states that debt is high. At the very bottom of the report in the Summary section it mentions that that this company has strong balance sheet. Furthermore, this section and and "Key risks" section do not mention any concerns with debt. Is this something we should be concerned with? (Note; I normally look at the debt on the balance sheet but have difficulties understanding how to interpret this number for financial institutions as they have customer deposits on-hand as debt OR they would need to borrow money to lend it out which is also debt. Do you know of any articles that help explain this).

3. Do you think the business model is sustainable? I went on their web site and rates start at 30% for personal loans. That is high, really high (I feel).

Thanks again. Walter.
P.S. I recently posted a question and must have accidently posted it as private. If you want to make it public, please do so.

Q: In a response to Craig on 19 Jan you stated that "Without reference to goals or risk, we would side with the significantly larger and more diversified BAMR". TD Waterhouse lists the market cap for BAMR at $534 million whereas TSU is listed at $1.8 billion. However I see that on your profile page you list BAMR at $1.93 billion, only slightly higher than TSU.

Q: I am looking at ALC and CNR. What are the fundamental reasons that CNR commands a much higher P/E? Is this all about growth prospects? Also, how is "fair value" determined by Morningstar?

Q: Which, in your opinion, will provide a better return over the next 5 years: Shopify or Kinaxis?

Q: Current thoughts regarding Celestica please. They seem to be finally coming around.
Looking forward do you think they might sustain. Thanks.